MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-18-0168283
Taj Pharma India Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹5.27 Cr
▲ 1274% YoY
Net loss · FY 2025
₹89.07 Lakh
Net margin -16.9%
EBITDA · FY 2025
₹2.36 Cr
EBITDA margin 44.7%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹5.1 Cr
Secured borrowings
Company age
15 yrs
Est. 2011
Directors on board
4
As per MCA filings
About Taj Pharma India Limited
Data last updated:
Taj Pharma India Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 June 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33111MH2011PLC219226. Its GSTIN is 24AADCT8895L1ZK (Gujarat). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Abhishek Ranvir Singh and Shantanu Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.27 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹89.07 Lakh (net margin -16.9%) and EBITDA of ₹2.36 Cr (EBITDA margin 44.7%). Revenue has grown at a compounded annual rate (CAGR) of 290% over three years and 34% over five years.
As per MCA filings, the company has open charges of ₹5.1 Cr on record. Court records list 3 cases involving the company, including 3 filed against it; 2 cases are pending.
Taj Pharma India Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0168283). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tajpharmaindia.com.
Company Details of Taj Pharma India Limited
CIN U33111MH2011PLC219226
Registration Number 219226
Incorporation Date 28 June 2011
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-18-0168283
Key People
Abhishek Ranvir Singh Director Shantanu Kumar Singh Director Priyanka Singh Additional Director Recognitions & Rankings of Taj Pharma India
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address905 9th Floor The Avenue Bldg Marol Village Navpada Marol Andheri E, Ast, Mumbai, Maharashtra, India – 400059
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Taj Pharma India Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Taj Pharma India Limited
The main business activity of Taj Pharma India is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Taj Pharma India Limited FY 2024 filings available
Taj Pharma India Limited reported revenue of ₹5.27 Cr (up 1274% YoY) for FY 2025.
Revenue · FY 2025
₹5.27 Cr ▲ 1274%
Net loss · FY 2025
₹89.07 Lakh margin -16.9%
EBITDA · FY 2025
₹2.36 Cr margin 44.7%
Compounded Annual Growth Rate (CAGR) of Taj Pharma India Limited
Revenue CAGR growth
3 years · compounded
▲ 290%
5 years · compounded
▲ 34%
EBITDA CAGR growth
3 years · compounded
▲ 479%
5 years · compounded
▲ 99%
Revenue has grown at a compounded annual rate (CAGR) of 34% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Taj Pharma India Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.36 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹89.07 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Taj Pharma India Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 44.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -16.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Taj Pharma India are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Taj Pharma India Limited
Taj Pharma India has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhishek Ranvir Singh Also directs: Arcelor Petroleum Limited, Arcelor Chemicals Private Limited, Taj Pharmaceuticals Limited and 5 more | Director | 28 Jun 2011 | 15 Years 3 Months | Current |
| Shantanu Kumar Singh Also directs: Arcelor Laboratories Private Limited, Humogen Serum Private Limited, Taj Institute of Medical Sciences Private Limited and 4 more | Director | 28 Jun 2011 | 15 Years 3 Months | Current |
| Priyanka Singh Also directs: Arcelor Petroleum Limited, Mulberry Chemicals Private Limited, Arcelor Laboratories Private Limited and 5 more | Additional Director | 27 Jul 2021 | 5 Years 2 Months | Current |
| Ranvir Kumar Bindeshwari Singh Also directs: Taj Serum Institute LLP, Taj Pharma Healthcare LLP, Arcelor Petroleum Limited and 5 more | Director | 11 Dec 2012 | 13 Years 10 Months | Current |
Peer Comparison of Taj Pharma India Limited
Taj Pharma India Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Edence Life Sciences Private Limited | ₹5.29 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Mumbai, Maharashtra, India |
| Synnova Intermediates Private Limited | ₹5.29 Cr (FY 2025) | •••• | •••• | 18325.0% | •••• | Mumbai, Maharashtra, India |
| Axolab Formulations Private Limited | ₹5.29 Cr (FY 2025) | •••• | •••• | 824.0% | •••• | Solan, Himachal Pradesh, India |
| SPR Oncocare Private Limited | ₹5.28 Cr (FY 2025) | •••• | •••• | 80.0% | •••• | Bangalore, Karnataka, India |
| Sure for Cure Farmulations (India ) Private Limited | ₹5.27 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Uttar Pradesh, India |
| Taj Pharma India Limited this company | ₹5.27 Cr (FY 2025) | •••• | •••• | 1274.0% | •••• | Mumbai, Maharashtra, India |
| Santo Medi Sciences Private Limited | ₹5.27 Cr (FY 2024) | •••• | •••• | -2.0% | •••• | Varanasi, Uttar Pradesh, India |
| Cureill Pharma Private Limited | ₹5.26 Cr (FY 2025) | •••• | •••• | -31.0% | •••• | Ahmedabad, Gujarat, India |
| R K Sports Private Limited | ₹5.26 Cr (FY 2024) | •••• | •••• | 18.0% | •••• | Jalandhar, Punjab, India |
| Boffin Biotech Private Limited | ₹5.26 Cr (FY 2024) | •••• | •••• | -9.0% | •••• | Haryana, India |
| Dew Drops Laboratories Private Limited | ₹5.25 Cr (FY 2024) | •••• | •••• | 10.0% | •••• | Khambhat, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Taj Pharma India by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Taj Pharma India Limited
Taj Pharma India Limited is audited by HEMAL PARIKH & CO. LLP for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| HEMAL PARIKH & CO. LLP | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Taj Pharma India Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Taj Pharma India Limited
Open charges
₹5.1 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Sep 2022 | Indian Overseas Bank | ₹5.1 Cr | Open |
Total charge records: 1 View all charges
Legal Cases of Taj Pharma India Limited
Taj Pharma India Limited has 3 court cases on record: 3 filed against it. 2 cases are pending and 1 is disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Total cases
3
Filed against the company
3
Pending
2
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 2 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Valsad, Gujarat | Commercial matter | Filed against the company by Vishwakarma Industries | Pending |
| District court, Valsad, Gujarat | Criminal complaint | Filed against the company by P.N.Chorera, Government Labour Officer and Minimum Wages Inspector | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed against the company by Registrar of Companies | Disposed |
Premium access
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Taj Pharma India Limited
Employment history and EPFO contributions of people linked to Taj Pharma India.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Taj Pharma India Limited
Taj Pharma India Limited has 9 board changes on record since 2011: 4 appointments and 5 cessations. The latest: Priyanka Singh was appointed as Additional Director on 27 Jul 2021.
AGM
Taj Pharma India Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Taj Pharma India Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Indian Overseas Bank amounted to Rs. 510.00 Lakh with Charge ID 100623322 was registered on 22 Sep 2022.
Appointed
Priyanka Singh was appointed as Additional Director.
Ceased
Salman Taiyebi ceased to be Additional Director.
Ceased
Taiyebi Mohammed ceased to be Additional Director.
Ceased
Priyanka Singh ceased to be Director.
Ceased
Sushma Singh ceased to be Director.
Appointed
Ranvir Kumar Bindeshwari Singh was appointed as Director.
Ceased
Ranvir Kumar Bindeshwari Singh ceased to be Director.
Appointed
Abhishek Ranvir Singh was appointed as Director.
Appointed
Shantanu Kumar Singh was appointed as Director.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Taj Pharma India Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Taj Pharma India Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Taj Pharma India Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Taj Pharma India Limited
Taj Pharma India has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AADCT8895L1ZK | Gujarat | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Taj Pharma India Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Taj Pharma India Limited
Frequently Asked Questions about Taj Pharma India Limited
Taj Pharma India is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 June 2011 (15+ years old) and is registered under CIN U33111MH2011PLC219226.
Taj Pharma India reported revenue of ₹5.27 Cr for FY 2025 (up 1274% YoY).
Taj Pharma India has 4 current directors:
- Abhishek Ranvir Singh - Director
- Shantanu Kumar Singh - Director
- Priyanka Singh - Additional Director
- Ranvir Kumar Bindeshwari Singh - Director
Taj Pharma India reported a net loss of ₹89.07 Lakh (net margin -16.9%) and EBITDA of ₹2.36 Cr (EBITDA margin 44.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Taj Pharma India is 290% over three years and 34% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Taj Pharma India is 24AADCT8895L1ZK, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Taj Pharma India is U33111MH2011PLC219226. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Taj Pharma India has 3 court cases on record: 3 filed against it. 2 are pending.
Taj Pharma India was incorporated on 28 June 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Taj Pharma India by revenue are Edence Life Sciences Private Limited, Synnova Intermediates Private Limited, Axolab Formulations Private Limited, SPR Oncocare Private Limited, Sure for Cure Farmulations (India ) Private Limited and 5 more, all in the Pharma industry (Formulations).
Priyanka Singh was appointed as Additional Director on 27 Jul 2021. Salman Taiyebi ceased to be Additional Director on 29 Sep 2018. Taiyebi Mohammed ceased to be Additional Director on 29 Sep 2018. Taj Pharma India has 9 board changes on record in total.